A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)

Exclusion Criteria

• •Hypersensitivity or a history of allergic reaction to botulinum toxin of any serotype or any of their formulation ingredients.
• •Any medical condition that may put the participant at increased risk with exposure to botulinum toxin of any serotype, or any disorders that might interfere with neuromuscular function.
• •Any serious disease or disorder that could interfere with the safe completion of treatment or with study outcome assessments, or compromise participant safety.
• •Botulinum toxin treatment in the face (below the lower orbital rim), jawline, or neck within the last seven months.
• •History of lower face surgery, neck or chest surgery, aesthetic procedures, and orthodontic procedures in the past 12 months.
• •Planned surgery or aesthetic procedures to the lower face, neck, or chest during the study period.
• •Anticipated need for treatment with botulinum toxin of any serotype for any indication during the study (other than study products).